Regulation of advanced therapies in Europe: Are we on the right track?
Cell Stem Cell · 2023-08 · 30 (8) · 1013-1016
DOI: 10.1016/j.stem.2023.07.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2023-08. Verfasst von Ander Izeta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Donostia University Hospital and Biodonostia Health Research Institute, Advanced Therapies Unit, Paseo Dr. Begiristain s/n, 20014, Donostia-San Sebas…. Hauptthemen laut MEDLINE: Marketing, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Donostia University Hospital and Biodonostia Health Research Institute, Advanced Therapies Unit, Paseo Dr. Begiristain s/n, 20014, Donostia-San Sebastian, Spain. Electronic address: ander.izetapermisan@osakidetza.eus.
- Andalusian Transplant Coordination, Servicio Andaluz de Salud, Avda. de la Constitución 18, 41071, Seville, Spain. Electronic address: natividad.cuende.sspa@juntadeandalucia.es.
Förderung
- Instituto de Salud Carlos III
- European Commission
Zitieren
APA
Izeta, A., & Cuende, N. (2023). Regulation of advanced therapies in Europe: Are we on the right track?. Cell Stem Cell, 30(8), 1013-1016. https://doi.org/10.1016/j.stem.2023.07.004
Vancouver
Izeta A, Cuende N. Regulation of advanced therapies in Europe: Are we on the right track?. Cell Stem Cell. 2023;30(8):1013-1016. doi:10.1016/j.stem.2023.07.004
BibTeX
@article{Izeta2023,
author = {Izeta, Ander and Cuende, Natividad},
title = {Regulation of advanced therapies in Europe: Are we on the right track?},
journal = {Cell Stem Cell},
year = {2023},
volume = {30},
number = {8},
pages = {1013--1016},
doi = {10.1016/j.stem.2023.07.004}
}
EUVIMED